X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with K.S.Oils Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs K.S.OILS LTD - Comparison Results

K.S.OILS LTD 
   Change

K S Oils (KSO), established in 1985, with crushing capacity of 1,475 metric tones per day of mustard seeds is one of the largest manufacturers of mustard oil in India. It enjoys a 4.5% share of total mustard oil market with a dominant 25% market shar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES K.S.OILS LTD AMAR REMEDIES/
K.S.OILS LTD
 
P/E (TTM) x -0.5 -0.1 - View Chart
P/BV x 0.1 0.2 28.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMAR REMEDIES   K.S.OILS LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
K.S.OILS LTD
Dec-12
AMAR REMEDIES/
K.S.OILS LTD
5-Yr Chart
Click to enlarge
High Rs16423 716.2%   
Low Rs864 2,205.1%   
Sales per share (Unadj.) Rs261.675.6 346.1%  
Earnings per share (Unadj.) Rs17.4-29.3 -59.4%  
Cash flow per share (Unadj.) Rs22.3-27.2 -82.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.72.1 4,835.0%  
Shares outstanding (eoy) m26.16459.18 5.7%   
Bonus/Rights/Conversions -PP-  
Price / Sales ratio x0.50.2 269.5%   
Avg P/E ratio x7.2-0.5 -1,569.4%  
P/CF ratio (eoy) x5.6-0.5 -1,136.8%  
Price / Book Value ratio x1.26.4 19.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,2706,153 53.1%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m163338 48.2%   
Avg. sales/employee Rs ThNM50,300.6-  
Avg. wages/employee Rs ThNM489.9-  
Avg. net profit/employee Rs ThNM-19,473.0-  
INCOME DATA
Net Sales Rs m6,84434,707 19.7%  
Other income Rs m2171 29.5%   
Total revenues Rs m6,86534,779 19.7%   
Gross profit Rs m1,131-5,731 -19.7%  
Depreciation Rs m128965 13.3%   
Interest Rs m3984,417 9.0%   
Profit before tax Rs m626-11,041 -5.7%   
Minority Interest Rs m022 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-2,277 2.2%   
Tax Rs m121140 86.6%   
Profit after tax Rs m455-13,436 -3.4%  
Gross profit margin %16.5-16.5 -100.1%  
Effective tax rate %19.3-1.3 -1,527.7%   
Net profit margin %6.6-38.7 -17.2%  
BALANCE SHEET DATA
Current assets Rs m4,90420,418 24.0%   
Current liabilities Rs m3,58117,967 19.9%   
Net working cap to sales %19.37.1 273.8%  
Current ratio x1.41.1 120.5%  
Inventory Days Days124109 114.0%  
Debtors Days Days10081 123.7%  
Net fixed assets Rs m1,68911,828 14.3%   
Share capital Rs m2623,058 8.6%   
"Free" reserves Rs m2,358-2,843 -82.9%   
Net worth Rs m2,635957 275.5%   
Long term debt Rs m50712,919 3.9%   
Total assets Rs m6,86233,013 20.8%  
Interest coverage x2.6-1.5 -171.5%   
Debt to equity ratio x0.213.5 1.4%  
Sales to assets ratio x1.01.1 94.9%   
Return on assets %12.4-27.3 -45.5%  
Return on equity %17.3-1,404.6 -1.2%  
Return on capital %31.0-64.0 -48.4%  
Exports to sales %4.00 15,213.6%   
Imports to sales %00-   
Exports (fob) Rs m2739 3,000.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27345 613.5%   
Fx outflow Rs m218 11.4%   
Net fx Rs m27127 1,007.4%   
CASH FLOW
From Operations Rs m-313-97 323.5%  
From Investments Rs m-489676 -72.3%  
From Financial Activity Rs m769-603 -127.4%  
Net Cashflow Rs m-33-24 134.3%  

Share Holding

Indian Promoters % 25.5 9.1 280.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.5 1,840.0%  
FIIs % 0.0 3.2 -  
ADR/GDR % 0.0 10.5 -  
Free float % 65.3 76.7 85.1%  
Shareholders   13,061 139,498 9.4%  
Pledged promoter(s) holding % 99.7 100.0 99.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   LINC PEN & PLASTICS LTD  ARCHIES LTD  RELAXO FOOTWEARS  BAJAJ CORP  MARICO LTD  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying(11:30 am)

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - KARUTURI GLOBAL COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS